Researchers at Penn Medicine created an innovative cancer treatment using nano-sized capsules that can target and trigger cancer cell self-destruction.
About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.
For the almost 520,000 Americans who will undergo treatment this year, the process leaves little room for a full life. An innovative new device could change everything.
Researchers at the University of Copenhagen and NTU Singapore have discovered that RNA damage, not DNA damage, is the real trigger for the acute effec ...
Trump’s executive order on “Gender Ideology Extremism and Restoring Biological Truth to the Federal Government,” intended as an attack on transgender American s and disingenuously disguised as ...
Alcohol use remains one of the most preventable risk factors for cancer. Even moderate alcohol consumption – one or fewer drinks per day – may elevate cancer risk for some types, such as breast, ...